Balasa Dinverno & Foltz’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $549K | Sell |
6,641
-303
| -4% | -$29.2K | 0.03% | 191 |
|
|
2022
Q2 | $660K | Sell |
6,944
-57
| -0.8% | -$5.9K | 0.04% | 169 |
|
|
2022
Q1 | $824K | Buy |
7,001
+706
| +11% | +$79.2K | 0.06% | 144 |
|
|
2021
Q4 | $816K | Buy |
6,295
+118
| +2% | +$13.8K | 0.05% | 151 |
|
|
2021
Q3 | $699K | Buy |
6,177
+1,320
| +27% | +$151K | 0.05% | 158 |
|
|
2021
Q2 | $503K | Buy |
4,857
+101
| +2% | +$9.52K | 0.04% | 186 |
|
|
2021
Q1 | $398K | Sell |
4,756
-69
| -1% | -$5.83K | 0.03% | 199 |
|
|
2020
Q4 | $440K | Buy |
4,825
+28
| +0.6% | +$2.32K | 0.04% | 178 |
|
|
2020
Q3 | $383K | Sell |
4,797
-171
| -3% | -$13.3K | 0.04% | 182 |
|
|
2020
Q2 | $343K | Sell |
4,968
-11,634
| -70% | -$827K | 0.04% | 161 |
|
|
2020
Q1 | $1.04M | Sell |
16,602
-1,383
| -8% | -$99.7K | 0.13% | 78 |
|
|
2019
Q4 | $1.4M | Buy |
17,985
+504
| +3% | +$39.4K | 0.15% | 67 |
|
|
2019
Q3 | $1.28M | Buy |
17,481
+735
| +4% | +$51.6K | 0.15% | 77 |
|
|
2019
Q2 | $1.03M | Sell |
16,746
-3
| -0% | -$181 | 0.12% | 83 |
|
|
2019
Q1 | $1.07M | Buy |
16,749
+561
| +3% | +$32K | 0.13% | 73 |
|
|
2018
Q4 | $827K | Sell |
16,188
-1,911
| -11% | -$96.7K | 0.1% | 89 |
|
|
2018
Q3 | $1.05M | Hold |
18,099
| – | – | 0.12% | 70 |
|
|
2018
Q2 | $878K | Sell |
18,099
-129
| -0.7% | -$6.02K | 0.13% | 72 |
|
|
2018
Q1 | $848K | Hold |
18,228
| – | – | 0.13% | 70 |
|
|
2017
Q4 | $685K | Sell |
18,228
-300
| -2% | -$11K | 0.1% | 90 |
|
|
2017
Q3 | $675K | Hold |
18,528
| – | – | 0.11% | 81 |
|
|
2017
Q2 | $730K | Sell |
18,528
-300
| -2% | -$10.9K | 0.12% | 78 |
|
|
2017
Q1 | $590K | Sell |
18,828
-720
| -4% | -$22.5K | 0.1% | 85 |
|
|
2016
Q4 | $611K | Sell |
19,548
-825
| -4% | -$26.7K | 0.1% | 80 |
|
|
2016
Q3 | $819K | Sell |
20,373
-96
| -0.5% | -$3.62K | 0.15% | 61 |
|
|
2016
Q2 | $680K | Buy |
20,469
+1,437
| +8% | +$49.2K | 0.12% | 68 |
|
|
2016
Q1 | $560K | Buy |
19,032
+36
| +0.2% | +$993 | 0.1% | 79 |
|
|
2015
Q4 | $500K | Sell |
18,996
-186
| -1% | -$4.83K | 0.08% | 95 |
|
|
2015
Q3 | $455K | Sell |
19,182
-576
| -3% | -$13.9K | 0.08% | 98 |
|
|
2015
Q2 | $469K | Sell |
19,758
-30
| -0.2% | -$677 | 0.08% | 97 |
|
|
2015
Q1 | $470K | Buy |
19,788
+2,712
| +16% | +$60.8K | 0.07% | 90 |
|
|
2014
Q4 | $363K | Buy |
17,076
+204
| +1% | +$4.1K | 0.05% | 126 |
|
|
2014
Q3 | $287K | Sell |
16,872
-1,452
| -8% | -$22.9K | 0.04% | 135 |
|
|
2014
Q2 | $262K | Buy |
18,324
+120
| +0.7% | +$1.63K | 0.03% | 144 |
|
|
2014
Q1 | $225K | Buy |
+18,204
| New | +$210K | 0.03% | 154 |
|
|
2013
Q4 | – | Sell |
-18,204
| Closed | -$211K | – | 157 |
|
|
2013
Q3 | $211K | Buy |
+18,204
| New | +$213K | 0.04% | 138 |
|
Other funds holding EW
Balasa Dinverno & Foltz's EW Position: Q3 2022 in Review
Balasa Dinverno & Foltz reduced its Edwards Lifesciences (EW) stake by 4.4% in Q3 2022, selling an estimated $29.2K and leaving 6,641 shares worth $549K. The position accounts for 0.03% of the portfolio, ranked #191.
Balasa Dinverno & Foltz first reported a position in EW in Q3 2013 and has held it in 36 quarters since. The position peaked at $1.4M in Q4 2019. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.
- Balasa Dinverno & Foltz held 6,641 shares of Edwards Lifesciences worth $549K as of Q3 2022.
- Balasa Dinverno & Foltz sold 303 Edwards Lifesciences shares in Q3 2022, an estimated $29.2K.
- Edwards Lifesciences made up 0.03% of Balasa Dinverno & Foltz's portfolio in Q3 2022, its #191 holding.
- Balasa Dinverno & Foltz first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 36 quarters since.
- Balasa Dinverno & Foltz's Edwards Lifesciences position peaked at $1.4M in Q4 2019.
- 1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.
Based on Balasa Dinverno & Foltz's 13F filing for Q3 2022, filed 25 Oct 2022.